" class="no-js "lang="en-US"> Albert Bourla Archives - Medtech Alert
Thursday, April 11, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States […]

Pfizer Names David M. Denton Chief Financial Officer

Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as […]

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19

Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 […]

Pfizer Announces New Chief Business Innovation Officer Aamir Malik

Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive […]

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent […]

Pfizer Announces New Investor Relations Leader

Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more